Oruka Therapeutics, Inc. (ORKA) — Net Asset Quality Index
Oruka Therapeutics, Inc. (ORKA) has a Net Asset Quality Index of 97.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.14 Billion minus total liabilities of $24.84 Million yields net assets of $1.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Explore ORKA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Oruka Therapeutics, Inc. Net Asset Quality Index Over Time (2005–2025)
This chart shows how Oruka Therapeutics, Inc.'s Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the index stands at 97.8%, representing net assets of $1.11 Billion against total assets of $1.14 Billion USD. See what is Oruka Therapeutics, Inc.'s book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Oruka Therapeutics, Inc. (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Oruka Therapeutics, Inc. from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ORKA stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.6% | $471.93 Million | $488.62 Million | $16.69 Million | ▲ +0.1 pp |
| 2024 | 96.5% | $382.22 Million | $396.02 Million | $13.80 Million | ▼ -1.3 pp |
| 2023 | 97.8% | $37.02 Million | $37.86 Million | $841.00K | ▲ +1.1 pp |
| 2022 | 96.7% | $41.67 Million | $43.09 Million | $1.41 Million | ▲ +3.8 pp |
| 2021 | 92.9% | $51.04 Million | $54.92 Million | $3.88 Million | ▲ +0.7 pp |
| 2020 | 92.3% | $46.52 Million | $50.43 Million | $3.91 Million | ▲ +3.1 pp |
| 2019 | 89.2% | $7.61 Million | $8.54 Million | $926.00K | ▲ +0.8 pp |
| 2018 | 88.4% | $6.03 Million | $6.83 Million | $793.00K | ▲ +5.3 pp |
| 2017 | 83.1% | $10.28 Million | $12.37 Million | $2.09 Million | ▼ -7.0 pp |
| 2016 | 90.1% | $22.19 Million | $24.63 Million | $2.44 Million | ▼ -6.1 pp |
| 2015 | 96.2% | $38.07 Million | $39.57 Million | $1.50 Million | ▲ +4.8 pp |
| 2014 | 91.4% | $14.74 Million | $16.13 Million | $1.39 Million | ▲ +0.2 pp |
| 2013 | 91.2% | $15.58 Million | $17.08 Million | $1.50 Million | ▲ +0.7 pp |
| 2012 | 90.5% | $2.91 Million | $3.21 Million | $305.00K | ▲ +2.3 pp |
| 2011 | 88.2% | $5.73 Million | $6.50 Million | $770.00K | ▲ +5.1 pp |
| 2010 | 83.0% | $6.77 Million | $8.16 Million | $1.39 Million | ▲ +3.9 pp |
| 2009 | 79.1% | $7.41 Million | $9.37 Million | $1.96 Million | ▲ +127.0 pp |
| 2008 | -48.0% | $-5.31 Million | $11.08 Million | $16.39 Million | ▼ -104.0 pp |
| 2007 | 56.1% | $67.66 Million | $120.68 Million | $53.02 Million | ▲ +18.2 pp |
| 2006 | 37.9% | $69.84 Million | $184.41 Million | $114.56 Million | ▼ -14.7 pp |
| 2005 | 52.5% | $56.76 Million | $108.05 Million | $51.28 Million | — |